DCM
GMED icon

Driehaus Capital Management’s Globus Medical GMED Stock Holding History

Driehaus Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-167,468
Closed -$14.4M – 390
2026
Q1 		$14.4M Sell
167,468
-294
-0.2% -$26.4K 0.11% 243
2025
Q4 		$14.6M Buy
+167,762
New +$12.7M 0.1% 236
2025
Q2 		– Sell
-873,784
Closed -$64M – 450
2025
Q1 		$64M Buy
873,784
+328,040
+60% +$27.1M 0.62% 41
2024
Q4 		$45.1M Buy
+545,744
New +$43M 0.37% 96
2021
Q4 		– Sell
-80,542
Closed -$6.17M – 402
2021
Q3 		$6.17M Buy
80,542
+72,071
+851% +$5.79M 0.07% 297
2021
Q2 		$657K Buy
+8,471
New +$602K 0.01% 361
2019
Q2 		– Sell
-7,000
Closed -$346K – 496
2019
Q1 		$346K Buy
+7,000
New +$317K 0.01% 346
2013
Q3 		– Sell
-48,206
Closed -$813K – 470
2013
Q2 		$813K Buy
+48,206
New +$744K 0.04% 360

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Driehaus Capital Management's GMED Position: Q2 2026 in Review

Driehaus Capital Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 167,468 shares — an estimated $14.4M sold.

Driehaus Capital Management first reported a position in GMED in Q2 2013 and held it in 8 quarters. The position peaked at $64M in Q1 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Driehaus Capital Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 167,468 Globus Medical shares in Q2 2026, an estimated $14.4M.
  • Driehaus Capital Management first reported a position in Globus Medical in Q2 2013 and held it in 8 quarters.
  • Driehaus Capital Management's Globus Medical position peaked at $64M in Q1 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.